Investigators: Ji Qiu, Ph.D.
Collaborators: Rafael Fonseca, M.D. (Mayo Clinic)
|Who gets it?
What are the symptoms?
|How do we detect it now?
How is it currently treated?
|What are the current challenges?|
Because of the possibly connection between the immune system and POEMS syndrome, we sought to identify autoantibodies reactive in the blood of POEMS patients. In an ongoing project, we have been using the NAPPA protein array technology to identify biomarkers for this disease with the goal of it helping us better understand the cause of POEMS and develop targeted treatments for this disease.